| Jangka masa | Harga Ramalan | lalu | Bersejarah | Wawasan |
|---|---|---|---|---|
| Esok | $6.03 ▲ +2.03% | Semalam | $5.86 ▼ -0.85% | Tomorrow's Sagimet Biosciences Inc. Series A Common Stock (SGMT) setup is anchored to $5.91 and targets $6.03 (+2.03%). The near-term read is upside; watch $6.09 / $5.73 because daily realized volatility is about 8.00%. |
Tomorrow's Sagimet Biosciences Inc. Series A Common Stock (SGMT) setup is anchored to $5.91 and targets $6.03 (+2.03%). The near-term read is upside; watch $6.09 / $5.73 because daily realized volatility is about 8.00%. | ||||
| Minggu | $6.28 ▲ +6.31% | Minggu lepas | $5.75 ▼ -2.65% | The 7-day Sagimet Biosciences Inc. Series A Common Stock model moves from $5.75 to $6.28 (+6.31%). It gives upside momentum context for this stock, so breaks around $6.09 / $5.73 matter more than a single tick. |
The 7-day Sagimet Biosciences Inc. Series A Common Stock model moves from $5.75 to $6.28 (+6.31%). It gives upside momentum context for this stock, so breaks around $6.09 / $5.73 matter more than a single tick. | ||||
| bulan | $6.70 ▲ +13.45% | Bulan lepas | $5.58 ▼ -5.65% | The 1-month Sagimet Biosciences Inc. Series A Common Stock target is $6.70 (+13.45%), compared with the live reference near $5.91. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Sagimet Biosciences Inc. Series A Common Stock target is $6.70 (+13.45%), compared with the live reference near $5.91. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| tahun | $7.34 ▲ +24.14% | Tahun lepas | $5.31 ▼ -10.14% | The 1-year Sagimet Biosciences Inc. Series A Common Stock scenario points to $7.34 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Sagimet Biosciences Inc. Series A Common Stock scenario points to $7.34 (+24.14%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Tahun | $8.82 ▲ +49.20% | 5 Tahun Lalu | $4.69 ▼ -20.66% | The 5-year Sagimet Biosciences Inc. Series A Common Stock view is $8.82 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Sagimet Biosciences Inc. Series A Common Stock view is $8.82 (+49.20%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Penunjuk | Nilai | Isyarat |
|---|---|---|
| Price | $5.91 | Mid |
| Daily Change | -8.23% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 75% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $5.91 | Daily Change | -8.23% |
| Market Cap | $192.58M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.